Ask your MP to support human relevant science

You can find contact details for your MP here: https://www.writetothem.com

Please copy the letter below or write your own – and remember to include your full name and address

Dear ………… MP

Animal research is not only one of the major moral issues of our time, it is also one of the major scientific issues. Studying human disease in animals often misleads our understanding of causes, progression and treatment because many insights gained from animals are simply not relevant to humans.

New methods based on human biology are transforming our ability to understand disease and develop new medicines. There is now a golden opportunity to transition science funding away from animal research, towards support for human relevant, non-animal biomedical research.

Please would you write to the Prime Minister to ask him to expedite strategic redirection of funding and regulatory engagement with human relevant new approach methodologies (NAMs) to revitalise the life sciences for the immediate benefit of human health and the economy.

For further information please see: SaferMedicines.org and  HumanRelevantScience.org, and consider joining the APPG on Human Relevant Science.

Yours sincerely,

Share
Follow Us

Latest Blog Posts

More harm than good? We need to talk about this!

As a patient safety charity whose raison d’etre is to reduce adverse drug reactions, Safer Medicines Trust is deeply concerned by the incidence of adverse reactions following covid-19 vaccinations. This is not what anyone wanted, following their remarkable development with such unprecedented speed – but it is certainly something that health systems should have been on high […]

‘Five For Friday’; Starting 2022 with five examples of human-relevant science using new approach methodologies (NAMs)

By Rebecca Ram Many research methods which focus on human-relevant biology (NAMs) are in use worldwide. However, a co-ordinated analysis of all existing methods that could be harmonised for global regulatory approval, as well as diversion of funding to the development of new methods are both long overdue. Encouraging signs were seen in Europe towards […]